Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

View:
Post by AbNormAl on Sep 14, 2016 6:21pm

Thumb twiddling...

I got up today to find 2/3's of my holding sold into trailing stop losses. I was a bit pizzed that I got moved off my position without the benefit of any real news.  Now, I am not so sure...  Good luck to those of you who stuck it through; this has been a long drawn out play.
Comment by biggerr on Sep 14, 2016 6:35pm
it happens very often that a pharma stock drops on the day when the approval is supposed to come, I remember the same thing happened to me many years ago when I had DDS - it was rising all the way before the approval date and when the approval came it dropped and subsequently went to zero because nobody was buying its slow-release anti-depressant drug, I lost lots of dough then, ah the memories
Comment by AbNormAl on Sep 14, 2016 6:46pm
I think this Adams CEO is too bright to get involved in the company without a very high level of confidence that the approval will come through. I simply never thought I would get hack-sawed out without actual negative news. My bad.  I still have a mid-sized bet on the table instead of an oversized one. Fingers crossed. I am sure many have chewed their nails down to the second knuckle on this ...more  
Comment by kuatolives on Sep 14, 2016 6:43pm
My worry is that they've been rejected and are spending this time crafting an investor response. It's almost 7pm est. If it's accepted, you fire that out immediately. If it's not, you spend time crafting. 6 beer in, but that's my thoughts. Question: if the fda responds, does ArlZ and ONLY ArlZ know, or is it a bullhorn?
Comment by gpgmay11 on Sep 14, 2016 7:12pm
SPPI was the other pharma company on the schedule today - they got a negative ruling and announced during hours. https://www.streetinsider.com/Corporate+News/Spectrum+Pharma+(SPPI)+Says+FDA+Advisory+Committee+Votes+that+Qapzola+Has+Not+Shown+Substantial+Evidence+of+Treatment+Effect+Over+Placebo/12032182.html
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities